» Articles » PMID: 30571483

Relationship Between Electrocardiographic Findings and Cardiac Magnetic Resonance Phenotypes in Arrhythmogenic Cardiomyopathy

Abstract

Background The new designation of arrhythmogenic cardiomyopathy defines a broader spectrum of disease phenotypes, which include right dominant, biventricular, and left dominant variants. We evaluated the relationship between electrocardiographic findings and contrast-enhanced cardiac magnetic resonance phenotypes in arrhythmogenic cardiomyopathy. Methods and Results We studied a consecutive cohort of patients with a definite diagnosis of arrhythmogenic cardiomyopathy, according to 2010 International Task Force criteria, who underwent electrocardiography and contrast-enhanced cardiac magnetic resonance. Both depolarization and repolarization electrocardiographic abnormalities were correlated with the severity of dilatation/dysfunction, either global or regional, of both ventricles and the presence and regional distribution of late gadolinium enhancement. The study population included 79 patients (60% men). There was a statistically significant relationship between the presence and extent of T-wave inversion across a 12-lead ECG and increasing values of median right ventricular ( RV ) end-diastolic volume ( P<0.001) and decreasing values of RV ejection fraction ( P<0.001). The extent of T-wave inversion to lateral leads predicted a more severe RV dilatation rather than a left ventricular involvement because of the leftward displacement of the dilated RV , as evidenced by contrast-enhanced cardiac magnetic resonance. A terminal activation delay of >55 ms in the right precordial leads (V1-V3) was associated with higher RV volume ( P=0.014) and lower RV ejection fraction ( P=0.053). Low QRS voltages in limb leads predicted the presence ( P=0.004) and amount ( P<0.001) of left ventricular late gadolinium enhancement. Conclusions The study results indicated that electrocardiographic abnormalities predict the arrhythmogenic cardiomyopathy phenotype in terms of severity of RV disease and left ventricular involvement, which are among the most important determinants of the disease outcome.

Citing Articles

The diagnostic value of electrocardiogram in the left variants of desmosomal arrhythmogenic cardiomyopathy.

Calo L, Toto F, Panattoni G, Romeo F, Fusco A, Stefanini M Eur Heart J Suppl. 2025; 27(Suppl 1):i83-i87.

PMID: 39980772 PMC: 11836698. DOI: 10.1093/eurheartjsupp/suae110.


Athlete's ECG Made Easy: A Practical Guide to Surviving Everyday Clinical Practice.

Fanale V, Segreti A, Fossati C, Di Gioia G, Coletti F, Crispino S J Cardiovasc Dev Dis. 2024; 11(10).

PMID: 39452274 PMC: 11508899. DOI: 10.3390/jcdd11100303.


The 2023 European Task Force Criteria for Diagnosis of Arrhythmogenic Cardiomyopathy: Historical Background and Review of Main Changes.

Graziano F, Zorzi A, Ungaro S, Bauce B, Rigato I, Cipriani A Rev Cardiovasc Med. 2024; 25(9):348.

PMID: 39355594 PMC: 11440389. DOI: 10.31083/j.rcm2509348.


New Diagnostic Approach to Arrhythmogenic Cardiomyopathy: The Padua Criteria.

Graziano F, Zorzi A, Cipriani A, De Lazzari M, Bauce B, Rigato I Rev Cardiovasc Med. 2024; 23(10):335.

PMID: 39077127 PMC: 11267345. DOI: 10.31083/j.rcm2310335.


Genetic background determines the severity of age-dependent cardiac structural abnormalities and arrhythmia susceptibility in Scn5a-1798insD mice.

Marchal G, Rivaud M, Wolswinkel R, Basso C, van Veen T, Bezzina C Europace. 2024; 26(6).

PMID: 38875491 PMC: 11203918. DOI: 10.1093/europace/euae153.


References
1.
Zorzi A, Rigato I, Pilichou K, Perazzolo Marra M, Migliore F, Mazzotti E . Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy. Europace. 2015; 18(7):1086-94. DOI: 10.1093/europace/euv205. View

2.
Rizzo S, Lodder E, Verkerk A, Wolswinkel R, Beekman L, Pilichou K . Intercalated disc abnormalities, reduced Na(+) current density, and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes. Cardiovasc Res. 2012; 95(4):409-18. DOI: 10.1093/cvr/cvs219. View

3.
Marcus F, McKenna W, Sherrill D, Basso C, Bauce B, Bluemke D . Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010; 121(13):1533-41. PMC: 2860804. DOI: 10.1161/CIRCULATIONAHA.108.840827. View

4.
Sato P, Musa H, Coombs W, Guerrero-Serna G, Patino G, Taffet S . Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. Circ Res. 2009; 105(6):523-6. PMC: 2742576. DOI: 10.1161/CIRCRESAHA.109.201418. View

5.
Norman M, Simpson M, Mogensen J, Shaw A, Hughes S, Syrris P . Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation. 2005; 112(5):636-42. DOI: 10.1161/CIRCULATIONAHA.104.532234. View